$AAPL
Apple Inc. Stock $aapl

$aapl Overview Financials Valuation SEC Filings Company Website

2012 Q3 Form 10-Q Financial Statement

#000119312512314552 Filed on July 25, 2012

Income Statement

Concept	2012 Q3	2012 Q2	2011 Q2
Revenue	$35.97B	$35.02B	$28.57B
YoY Change	27.22%	22.58%	81.98%
Cost Of Revenue	$21.57B	$20.03B	$16.65B
YoY Change	27.68%	20.3%	74.08%
Gross Profit	$14.40B	$14.99B	$11.92B
YoY Change	26.55%	25.77%	94.3%
Gross Profit Margin	40.04%	42.81%	41.73%
Selling, General & Admin	$2.551B	$2.545B	$1.915B
YoY Change	25.98%	32.9%	33.17%
% of Gross Profit	17.71%	16.97%	16.06%
Research & Development	$906.0M	$876.0M	$628.0M
YoY Change	40.47%	39.49%	35.34%
% of Gross Profit	6.29%	5.84%	5.27%
Depreciation & Amortization	$981.0M	$835.0M	$481.0M
YoY Change	80.66%	73.6%	76.19%
% of Gross Profit	6.81%	5.57%	4.03%
Operating Expenses	$3.457B	$3.421B	$2.543B
YoY Change	29.48%	34.53%	33.7%
Operating Profit	$10.94B	$11.57B	$9.379B
YoY Change	25.65%	23.39%	121.52%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$51.00M	$288.0M	$172.0M
YoY Change	-162.96%	67.44%	196.55%
Pretax Income	$10.89B	$11.86B	$9.551B
YoY Change	23.91%	24.19%	122.53%
Income Tax	$2.670B	$3.037B	$2.243B
% Of Pretax Income	24.51%	25.6%	23.48%
Net Earnings	$8.223B	$8.824B	$7.308B
YoY Change	24.16%	20.74%	124.65%
Net Earnings / Revenue	22.86%	25.19%	25.58%
Basic Earnings Per Share	$8.76	$9.42	$7.89
Diluted Earnings Per Share	$8.67	$9.32	$7.79
COMMON SHARES
Basic Shares Outstanding	937.4M shares	936.6M shares	926.1M shares
Diluted Shares Outstanding		947.1M shares	937.8M shares

Balance Sheet

Concept	2012 Q3	2012 Q2	2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$29.13B	$27.65B	$28.40B
YoY Change	12.24%	-2.61%	16.91%
Cash & Equivalents	$10.75B	$7.945B	$12.09B
Short-Term Investments	$18.38B	$19.71B	$16.30B
Other Short-Term Assets	$6.458B	$6.560B	$6.143B
YoY Change	42.59%	6.79%	39.49%
Inventory	$791.0M	$1.122B	$889.0M
Prepaid Expenses
Receivables	$10.93B	$7.657B	$6.102B
Other Receivables	$7.762B	$6.641B	$5.369B
Total Short-Term Assets	$57.65B	$51.94B	$46.90B
YoY Change	28.15%	10.76%	30.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.45B	$10.49B	$6.749B
YoY Change	98.69%	55.39%	69.15%
Goodwill	$1.135B	$1.132B
YoY Change	26.67%
Intangibles	$4.224B	$4.329B
YoY Change	19.46%
Long-Term Investments	$92.12B	$89.57B	$47.76B
YoY Change	65.63%	87.53%	121.62%
Other Assets	$5.478B	$5.438B	$3.440B
YoY Change	54.05%	58.08%	62.34%
Total Long-Term Assets	$118.4B	$111.0B	$59.86B
YoY Change	65.88%	85.35%	108.63%
TOTAL ASSETS
Total Short-Term Assets	$57.65B	$51.94B	$46.90B
Total Long-Term Assets	$118.4B	$111.0B	$59.86B
Total Assets	$176.1B	$162.9B	$106.8B
YoY Change	51.3%	52.58%	64.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.18B	$16.81B	$15.27B
YoY Change	44.72%	10.07%	80.3%
Accrued Expenses	$11.41B	$10.43B	$2.224B
YoY Change	23.43%	368.97%	63.53%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$38.54B	$33.06B	$26.86B
YoY Change	37.8%	23.09%	72.04%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$16.66B	$15.56B	$3.225B
YoY Change	64.99%	382.48%	48.34%
Total Long-Term Liabilities	$16.66B	$15.56B	$3.225B
YoY Change	64.99%	382.48%	48.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$38.54B	$33.06B	$26.86B
Total Long-Term Liabilities	$16.66B	$15.56B	$3.225B
Total Liabilities	$57.85B	$51.15B	$37.42B
YoY Change	45.52%	36.71%	73.11%
SHAREHOLDERS EQUITY
Retained Earnings	$101.3B	$95.64B
YoY Change	61.18%
Common Stock	$16.42B	$15.57B
YoY Change	23.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$118.2B	$111.7B	$69.34B
YoY Change
Total Liabilities & Shareholders Equity	$176.1B	$162.9B	$106.8B
YoY Change	51.3%	52.58%	64.94%

Cashflow Statement

Concept	2012 Q3	2012 Q2	2011 Q2
OPERATING ACTIVITIES
Net Income	$8.223B	$8.824B	$7.308B
YoY Change	24.16%	20.74%	124.65%
Depreciation, Depletion And Amortization	$981.0M	$835.0M	$481.0M
YoY Change	80.66%	73.6%	76.19%
Cash From Operating Activities	$9.136B	$10.19B	$11.11B
YoY Change	-12.4%	-8.27%	131.37%
INVESTING ACTIVITIES
Capital Expenditures	-$3.501B	-$2.963B	-$962.0M
YoY Change	-23.41%	208.0%	53.67%
Acquisitions
YoY Change
Other Investing Activities	-$812.0M	-$9.347B	-$14.07B
YoY Change	-90.52%	-33.57%	192.88%
Cash From Investing Activities	-$4.313B	-$12.31B	-$15.03B
YoY Change	-67.17%	-18.11%	176.83%
FINANCING ACTIVITIES
Cash Dividend Paid	$2.500B	$0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.022B	-55.00M	37.00M
YoY Change	-569.14%	-248.65%	-88.29%
NET CHANGE
Cash From Operating Activities	9.136B	10.19B	11.11B
Cash From Investing Activities	-4.313B	-12.31B	-15.03B
Cash From Financing Activities	-2.022B	-55.00M	37.00M
Net Change In Cash	2.801B	-2.176B	-3.887B
YoY Change	-223.07%	-44.02%	1141.85%
FREE CASH FLOW
Cash From Operating Activities	$9.136B	$10.19B	$11.11B
Capital Expenditures	-$3.501B	-$2.963B	-$962.0M
Free Cash Flow	$12.64B	$13.15B	$12.07B
YoY Change	-15.75%	8.96%	122.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q3	us-gaap	Stockholders Equity StockholdersEquity	76615000000
CY2012Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	937406000	shares
CY2011Q3	us-gaap	Goodwill Goodwill	896000000
CY2011Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	55618000000
CY2011Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11768000000
CY2011Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	2014000000
CY2011Q3	us-gaap	Other Assets Current OtherAssetsCurrent	4529000000
CY2011Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1240000000
CY2011Q3	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	6348000000
CY2011Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3556000000
CY2011Q3	us-gaap	Common Stock Value CommonStockValue	13331000000
CY2011Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1686000000
CY2011Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	1140000000
CY2011Q3	us-gaap	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax	290000000
CY2011Q3	us-gaap	Assets Current AssetsCurrent	44988000000
CY2011Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	81464000000
CY2011Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2011Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3641000000
CY2011Q3	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	23000000
CY2011Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1800000000	shares
CY2011Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	590000000
CY2011Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	929277000	shares
CY2011Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	563000000
CY2011Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2011Q3	us-gaap	Liabilities Liabilities	39756000000
CY2011Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	14632000000
CY2011Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1400000000
CY2011Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	16137000000
CY2011Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4091000000
CY2011Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	231.49
CY2011Q3	us-gaap	Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	9891000000
CY2011Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10100000000
CY2011Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	62841000000
CY2011Q3	us-gaap	Assets Assets	116371000000
CY2011Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	108.64
CY2011Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	8159000000
CY2011Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5369000000
CY2011Q3	us-gaap	Inventory Net InventoryNet	776000000
CY2011Q3	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	264000000
CY2011Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	116371000000
CY2011Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2599000000
CY2011Q3	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent	2038000000
CY2011Q3	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	598000000
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9815000000
CY2011Q3	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	158000000
CY2011Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	929277000	shares
CY2011Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3536000000
CY2011Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	443000000
CY2011Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	14446000	shares
CY2011Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9247000000
CY2011Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	184000000
CY2011Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	1941000000
CY2011Q3	us-gaap	Liabilities Current LiabilitiesCurrent	27970000000
CY2011Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	53000000
CY2011Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11866000	shares
CY2011Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	130000000
CY2011Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3991000000
CY2011Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7777000000
CY2011Q3	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	81570000000
CY2011Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	261000000
CY2011Q3	aapl	Credit Risk Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments CreditRiskAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	56000000
CY2011Q3	aapl	Land And Buildings Gross LandAndBuildingsGross	2059000000
CY2011Q3	aapl	Machinery Equipment And Internal Use Software Gross MachineryEquipmentAndInternalUseSoftwareGross	6926000000
CY2011Q3	aapl	Notional Amount Of Foreign Currency Derivative Instruments Designated As Hedging Instruments NotionalAmountOfForeignCurrencyDerivativeInstrumentsDesignatedAsHedgingInstruments	13705000000
CY2011Q3	aapl	Credit Risk Amount Of Foreign Currency Derivative Instruments Designated As Hedging Instruments CreditRiskAmountOfForeignCurrencyDerivativeInstrumentsDesignatedAsHedgingInstruments	537000000
CY2011Q3	aapl	Prepaid Expense Other Current Noncurrent PrepaidExpenseOtherCurrentNoncurrent	2300000000
CY2011Q3	aapl	Collateral Already Received Aggregate Fair Value CollateralAlreadyReceivedAggregateFairValue	288000000
CY2011Q3	aapl	Number Of Significant Vendors NumberOfSignificantVendors	2	Vendor
CY2011Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1103000000
CY2011Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1190000000
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12091000000
CY2012Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1678000000
CY2012Q2	us-gaap	Goodwill Goodwill	1132000000
CY2012Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	89567000000
CY2012Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16205000000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	38200000	shares
CY2012Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	2309000000
CY2012Q2	us-gaap	Other Assets Current OtherAssetsCurrent	6560000000
CY2012Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1565000000
CY2012Q2	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	6641000000
CY2012Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5438000000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7869000	shares
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	111746000000
CY2012Q2	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Estimated Range Of Change Upper Bound SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeUpperBound	170000000
CY2012Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	116712000000
CY2012Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4300000000
CY2012Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4642000000
CY2012Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3652052000
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-65000000
CY2012Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1800000000	shares
CY2012Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	765000000
CY2012Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1300000000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	119.93
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3702090000
CY2012Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	937266000	shares
CY2012Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	792000000
CY2012Q2	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	4500000000
CY2012Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2012Q2	us-gaap	Liabilities Liabilities	51150000000
CY2012Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	16808000000
CY2012Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1800000000
CY2012Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	19709000000
CY2012Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5822000000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	331.05
CY2012Q2	us-gaap	Notional Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments NotionalAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	10637000000
CY2012Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15560000000
CY2012Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	95641000000
CY2012Q2	us-gaap	Assets Assets	162896000000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	119.75
CY2012Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	13195000000
CY2012Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7657000000
CY2012Q2	us-gaap	Inventory Net InventoryNet	1122000000
CY2012Q2	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	581000000
CY2012Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	162896000000
CY2012Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3086000000
CY2012Q2	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent	1279000000
CY2012Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	581000000
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7945000000
CY2012Q2	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	72000000
CY2012Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	937266000	shares
CY2012Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4329000000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	105000	shares
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	532000000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	14902000	shares
CY2012Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10430000000
CY2012Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	228000000
CY2012Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2365000000
CY2012Q2	us-gaap	Liabilities Current LiabilitiesCurrent	33060000000
CY2012Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	94000000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7974000	shares
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	396000000
CY2012Q2	us-gaap	Common Stock Value CommonStockValue	15573000000
CY2012Q2	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Estimated Range Of Change Lower Bound SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeLowerBound	120000000
CY2012Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2530000000
CY2012Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	1598000000
CY2012Q2	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	3100000000
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax	201000000
CY2012Q2	us-gaap	Assets Current AssetsCurrent	51943000000
CY2012Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4100000000
CY2012Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5718000000
CY2012Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10487000000
CY2012Q2	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	117221000000
CY2012Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	343000000
CY2012Q2	aapl	Credit Risk Amount Of Foreign Currency Derivative Instruments Not Designated As Hedging Instruments CreditRiskAmountOfForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	40000000
CY2012Q2	aapl	Land And Buildings Gross LandAndBuildingsGross	2315000000
CY2012Q2	aapl	Off Balance Sheet Commitment Inventory Purchases OffBalanceSheetCommitmentInventoryPurchases	13600000000
CY2012Q2	aapl	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedTotalIntrinsicValue	8702991000
CY2012Q2	aapl	Machinery Equipment And Internal Use Software Gross MachineryEquipmentAndInternalUseSoftwareGross	10576000000
CY2012Q2	aapl	Operating Leases Future Minimum Payments Due Retail Space OperatingLeasesFutureMinimumPaymentsDueRetailSpace	3000000000
CY2012Q2	aapl	Notional Amount Of Foreign Currency Derivative Instruments Designated As Hedging Instruments NotionalAmountOfForeignCurrencyDerivativeInstrumentsDesignatedAsHedgingInstruments	33892000000
CY2012Q2	aapl	Credit Risk Amount Of Foreign Currency Derivative Instruments Designated As Hedging Instruments CreditRiskAmountOfForeignCurrencyDerivativeInstrumentsDesignatedAsHedgingInstruments	569000000
CY2012Q2	aapl	Prepaid Expense Other Current Noncurrent PrepaidExpenseOtherCurrentNoncurrent	4400000000
CY2012Q2	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Intrinsic Value At Period End ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestIntrinsicValueAtPeriodEnd	50039000
CY2012Q2	aapl	Collateral Already Received Aggregate Fair Value CollateralAlreadyReceivedAggregateFairValue	492000000
CY2012Q2	aapl	Number Of Countries NumberOfCountries	12	Country
CY2012Q2	aapl	Number Of Significant Vendors NumberOfSignificantVendors	2	Vendor
CY2012Q2	aapl	Long Term Marketable Securities Maturities Term Minimum LongTermMarketableSecuritiesMaturitiesTermMinimum	P1Y
CY2012Q2	aapl	Long Term Marketable Securities Maturities Term Maximum LongTermMarketableSecuritiesMaturitiesTermMaximum	P5Y
CY2012Q2	aapl	Major Facility Lease Terms Maximum Period MajorFacilityLeaseTermsMaximumPeriod	P10Y
CY2012Q2	aapl	Retail Lease Terms Majority Period RetailLeaseTermsMajorityPeriod	P10Y
CY2012Q2	aapl	Retail Lease Terms Maximum Period RetailLeaseTermsMaximumPeriod	P20Y
CY2012Q2	aapl	Retail Lease Terms Minimum Period RetailLeaseTermsMinimumPeriod	P5Y
CY2012Q2	aapl	Renewal Option Terms Maximum Additional Period RenewalOptionTermsMaximumAdditionalPeriod	P5Y
CY2012Q2	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Assumed Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedWeightedAverageExercisePrice	30.92
CY2012Q2	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice	106.00
CY2010Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	761000000
CY2010Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11261000000
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2608000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2100000000
	us-gaap	Operating Income Loss OperatingIncomeLoss	25080000000
	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	-103000000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2480000000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	577000000
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19734000000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	16396000000
	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	-291000000
	us-gaap	Share Based Compensation ShareBasedCompensation	870000000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	20.63
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2615000000
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	790000000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	47541000000
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	273000000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27100000000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27283000000
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	448000000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1276000000
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-175000000
	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	-701000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1400000000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	830000000
	us-gaap	Marketing Expense MarketingExpense	75000000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1551000000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	935688000	shares
	us-gaap	Sales Revenue Net SalesRevenueNet	79979000000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	592000000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	101000000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	25414000000
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	349000000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	20.91
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1784000000
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1219000000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1013000000
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	75133000000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	479000000
	us-gaap	Operating Expenses OperatingExpenses	7358000000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	922917000	shares
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-162000000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	12771000	shares
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2563000000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-34000000
	us-gaap	Gross Profit GrossProfit	32438000000
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	34301000000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	266000000
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	1271000000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2232000000
	us-gaap	Net Income Loss NetIncomeLoss	19299000000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	334000000
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	915000000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5574000000
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	955000000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6115000000
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	61000000
	aapl	Segment Reporting Information Corporate Expenses SegmentReportingInformationCorporateExpenses	4169000000
	aapl	Share Based Compensation Arrangement By Share Based Payment Award Stock Purchase Rights Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockPurchaseRightsGrantsInPeriodWeightedAverageGrantDateFairValue	67.70
	dei	Trading Symbol TradingSymbol	AAPL
	dei	Entity Registrant Name EntityRegistrantName	APPLE INC
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2012-06-30
	dei	Entity Central Index Key EntityCentralIndexKey	0000320193
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-29
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1686000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1500000000
	us-gaap	Operating Income Loss OperatingIncomeLoss	44297000000
	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	-246000000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2450000000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	433000000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y329D
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	350000000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	33599000000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	10344000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	7223000	shares
	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	347000000
	us-gaap	Share Based Compensation ShareBasedCompensation	1292000000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	35.48
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	103.35
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	4834000000
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1301000000
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3910000	shares
	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P3Y
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	66281000000
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.65
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-89000000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41720000000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-43914000000
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	-305000000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2575000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	5955000	shares
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	216000000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	85.19
	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	468000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	3100000000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1870000000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3238000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	202.92
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	414.88
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y146D
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	944440000	shares
	us-gaap	Sales Revenue Net SalesRevenueNet	120542000000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2278000000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-88000000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	44870000000
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	432000000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	35.89
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2475000000
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1626000000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	324000000
	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	10000000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	23000	shares
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	121091000000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1145000000
	us-gaap	Operating Expenses OperatingExpenses	9964000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	245.20
	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	302000000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	933672000	shares
CY2011	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	There were no customers that accounted for 10% or more of the Company’s trade receivables as of June 30, 2012 and September 24, 2011, respectively.
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	248000000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	346000000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	10768000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y329D
	us-gaap	Maximum Length Of Time Hedged In Cash Flow Hedge1 MaximumLengthOfTimeHedgedInCashFlowHedge1	P6M
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5901000000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	56000000
	us-gaap	Gross Profit GrossProfit	54261000000
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	73140000000
	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	There were no customers that accounted for 10% or more of the Company’s trade receivables as of June 30, 2012 and September 24, 2011, respectively.
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1067000000
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	2296000000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4066000000
	us-gaap	Net Income Loss NetIncomeLoss	33510000000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	573000000
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1036000000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7489000000
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	293000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11360000000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	812000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	400.79
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	266000000
	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm	P4Y329D
	aapl	Segment Reporting Information Corporate Expenses SegmentReportingInformationCorporateExpenses	4216000000
	aapl	Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriod	41000	shares
	aapl	Range Of Time Hedged In Cash Flow Hedge RangeOfTimeHedgedInCashFlowHedge	The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases generally up to six months.
	aapl	Purchase Commitment Maximum Period Required PurchaseCommitmentMaximumPeriodRequired	P150D
	aapl	Schedule Of Derivative Instruments Effect On Income And Other Comprehensive Income ScheduleOfDerivativeInstrumentsEffectOnIncomeAndOtherComprehensiveIncome	<div> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"> <font style="FONT-FAMILY: Times New Roman" size="2">The following tables show the pre-tax effect of the Company’s derivative instruments designated as cash flow and net investment hedges in the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 30, 2012 and June 25, 2011 (in millions):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="LINE-HEIGHT: 0pt; VISIBILITY: hidden; COLOR: white"> <td width="50%"></td> <td valign="bottom" width="3%"></td> <td></td> <td nowrap="nowrap"><font size="2"><b>                 </b></font></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td nowrap="nowrap"><font size="2"><b>                 </b></font></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td nowrap="nowrap"><font size="2"><b>                 </b></font></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td nowrap="nowrap"><font size="2"><b>                 </b></font></td> <td></td> <td valign="bottom" width="3%"></td> <td nowrap="nowrap"><font size="2"><b>                 </b></font></td> <td valign="bottom" width="3%"></td> <td></td> <td nowrap="nowrap"><font size="2"><b>                 </b></font></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td nowrap="nowrap"><font size="2"><b>                 </b></font></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="24" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Three Months Ended</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses)</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Recognized in  OCI -</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Effective Portion (e)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses)</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Reclassified  from AOCI</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>into Income -</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Effective Portion (e)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="8" align="center"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses) Recognized -<br /> Ineffective Portion and<br /> Amount Excluded from<br /> Effectiveness Testing</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June 30,<br /> 2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June 25,<br /> 2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June 30,<br /> 2012 (a)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June 25,<br /> 2011 (b)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Location</b></font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June 30,<br /> 2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June 25,<br /> 2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Cash flow hedges:</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign exchange contracts</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">234</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">12</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">84</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(162</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: Times New Roman" size="2">Other income</font></p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: Times New Roman" size="2">and expense</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(39</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">15</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net investment hedges:</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign exchange contracts</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(7</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: Times New Roman" size="2">Other income</font></p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: Times New Roman" size="2">and expense</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">237</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">84</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(162</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(38</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="LINE-HEIGHT: 0pt; VISIBILITY: hidden; COLOR: white"> <td width="52%"></td> <td valign="bottom" width="2%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>                 </b></font></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>                 </b></font></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>                 </b></font></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>                 </b></font></td> <td></td> <td valign="bottom" width="2%"></td> <td nowrap="nowrap"><font size="1"><b>                 </b></font></td> <td valign="bottom" width="2%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>                 </b></font></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td nowrap="nowrap"><font size="1"><b>                 </b></font></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="24" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Nine Months Ended</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses)<br /> Recognized in OCI -</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Effective Portion (e)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses)<br /> Reclassified from AOCI</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>into Income -</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Effective Portion (e)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="8" align="center"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Gains/(Losses) Recognized -<br /> Ineffective Portion and<br /> Amount Excluded from</b></font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Effectiveness Testing</b></font></p> </td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June 30,<br /> 2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June 25,<br /> 2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June 30,<br /> 2012 (c)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June 25,<br /> 2011 (d)</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Location</b></font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June 30,<br /> 2012</b></font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font size="1"> </font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June 25,<br /> 2011</b></font></td> <td valign="bottom"><font size="1"> </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Cash flow hedges:</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign exchange contracts</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">337</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(270</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">468</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(701</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: Times New Roman" size="2">Other income</font></p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: Times New Roman" size="2">and expense</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(248</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(104</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net investment hedges:</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"></td> <td valign="top"></td> <td valign="top"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Foreign exchange contracts</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">10</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(21</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: Times New Roman" size="2">Other income</font></p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: -1em; MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em"> <font style="FONT-FAMILY: Times New Roman" size="2">and expense</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2"> </font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 5em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">347</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(291</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">468</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">  </font></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(701</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">  </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(246</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> <td valign="bottom"><font size="1"> </font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(103</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">) </font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> <p style="BORDER-BOTTOM: #000000 0.5pt solid; LINE-HEIGHT: 8px; MARGIN-TOP: 0px; WIDTH: 10%; MARGIN-BOTTOM: 2px">  </p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a)</font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $63 million and $21 million were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the three months ended June 30, 2012. There were no amounts reclassified from AOCI into net income for the effective portion of net investment hedges for the three months ended June 30, 2012.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b)</font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $(101) million and $(61) million were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the three months ended June 25, 2011. There were no amounts reclassified from AOCI into net income for the effective portion of net investment hedges for the three months ended June 25, 2011.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c)</font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $404 million and $64 million were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the nine months ended June 30, 2012. There were no amounts reclassified from AOCI into net income for the effective portion of net investment hedges for the nine months ended June 30, 2012.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(d)</font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Includes gains/(losses) reclassified from AOCI into net income for the effective portion of cash flow hedges, of which $(382) million and $(319) million were recognized within net sales and cost of sales, respectively, within the Condensed Consolidated Statement of Operations for the nine months ended June 25, 2011. There were no amounts reclassified from AOCI into net income for the effective portion of net investment hedges for the nine months ended June 25, 2011.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(e)</font></td> <td valign="top" align="left"> <p align="justify"><font style="FONT-FAMILY: Times New Roman" size="2">Refer to Note 5, “Shareholders’ Equity and Share-based Compensation” of this Form 10-Q, which summarizes the activity in AOCI related to derivatives.</font></p> </td> </tr> </table> </div>
	aapl	Share Based Compensation Arrangement By Share Based Payment Award Stock Purchase Rights Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockPurchaseRightsGrantsInPeriodWeightedAverageGrantDateFairValue	102.41
	aapl	Prepaid Expense And Other Current Noncurrent Utilized PrepaidExpenseAndOtherCurrentNoncurrentUtilized	634000000
CY2011Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	9379000000
CY2011Q2	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	16000000
CY2011Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7571000000
CY2011Q2	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	5000000
CY2011Q2	us-gaap	Share Based Compensation ShareBasedCompensation	284000000
CY2011Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.79
CY2011Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	288000000
CY2011Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16649000000
CY2011Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	112000000
CY2011Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	104000000
CY2011Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	8000000
CY2011Q2	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	-162000000
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	637000000
CY2011Q2	us-gaap	Marketing Expense MarketingExpense	26000000
CY2011Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	937810000	shares
CY2011Q2	us-gaap	Sales Revenue Net SalesRevenueNet	28571000000
CY2011Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	11000000
CY2011Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9551000000
CY2011Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	113000000
CY2011Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.89
CY2011Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	628000000
CY2011Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	375000000
CY2011Q2	us-gaap	Operating Expenses OperatingExpenses	2543000000
CY2011Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	926108000	shares
CY2011Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11702000	shares
CY2011Q2	us-gaap	Gross Profit GrossProfit	11922000000
CY2011Q2	us-gaap	Net Income Loss NetIncomeLoss	7308000000
CY2011Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	172000000
CY2011Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1915000000
CY2011Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2243000000
CY2011Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	140000000
CY2011Q2	aapl	Segment Reporting Information Corporate Expenses SegmentReportingInformationCorporateExpenses	1359000000
CY2011Q2	aapl	Share Based Compensation Arrangement By Share Based Payment Award Stock Purchase Rights Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockPurchaseRightsGrantsInPeriodWeightedAverageGrantDateFairValue	72.63
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	332000000
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	11573000000
CY2012Q2	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	-38000000
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8832000000
CY2012Q2	us-gaap	Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet	237000000
CY2012Q2	us-gaap	Share Based Compensation ShareBasedCompensation	448000000
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.32
CY2012Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	436000000
CY2012Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	20029000000
CY2012Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	96000000
CY2012Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	-54000000
CY2012Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	150000000
CY2012Q2	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	84000000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1500000000
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	947059000	shares
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	35023000000
CY2012Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-91000000
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	11861000000
CY2012Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	131000000
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.42
CY2012Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	876000000
CY2012Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	323000000
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	3421000000
CY2012Q2	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	302000000
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	936596000	shares
CY2012Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	10463000	shares
CY2012Q2	us-gaap	Gross Profit GrossProfit	14994000000
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	8824000000
CY2012Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	288000000
CY2012Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2545000000
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3037000000
CY2012Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	3000000
CY2012Q2	aapl	Segment Reporting Information Corporate Expenses SegmentReportingInformationCorporateExpenses	1757000000
CY2012Q2	aapl	Share Based Compensation Arrangement By Share Based Payment Award Stock Purchase Rights Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockPurchaseRightsGrantsInPeriodWeightedAverageGrantDateFairValue	114.01
CY2012Q2	aapl	Prepaid Expense And Other Current Noncurrent Utilized PrepaidExpenseAndOtherCurrentNoncurrentUtilized	41000000

Files In Submission

Name	View Source	Status
0001193125-12-314552-index-headers.html	Edgar Link	completed
0001193125-12-314552-index.html	Edgar Link	completed
0001193125-12-314552.txt	Edgar Link	completed
0001193125-12-314552-xbrl.zip	Edgar Link	completed
aapl-20120630.xml	Edgar Link	completed
aapl-20120630.xsd	Edgar Link	completed
aapl-20120630_cal.xml	Edgar Link	unprocessable
aapl-20120630_def.xml	Edgar Link	unprocessable
aapl-20120630_lab.xml	Edgar Link	unprocessable
aapl-20120630_pre.xml	Edgar Link	unprocessable
d365704d10q.htm	Edgar Link	completed
d365704dex103.htm	Edgar Link	completed
d365704dex108.htm	Edgar Link	completed
d365704dex311.htm	Edgar Link	completed
d365704dex312.htm	Edgar Link	completed
d365704dex321.htm	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	completed
R1.htm	Edgar Link	completed
R10.htm	Edgar Link	completed
R11.htm	Edgar Link	completed
R12.htm	Edgar Link	completed
R13.htm	Edgar Link	completed
R14.htm	Edgar Link	completed
R15.htm	Edgar Link	completed
R16.htm	Edgar Link	completed
R17.htm	Edgar Link	completed
R18.htm	Edgar Link	completed
R19.htm	Edgar Link	completed
R2.htm	Edgar Link	completed
R20.htm	Edgar Link	completed
R21.htm	Edgar Link	completed
R22.htm	Edgar Link	completed
R23.htm	Edgar Link	completed
R24.htm	Edgar Link	completed
R25.htm	Edgar Link	completed
R26.htm	Edgar Link	completed
R27.htm	Edgar Link	completed
R28.htm	Edgar Link	completed
R29.htm	Edgar Link	completed
R3.htm	Edgar Link	completed
R30.htm	Edgar Link	completed
R31.htm	Edgar Link	completed
R32.htm	Edgar Link	completed
R33.htm	Edgar Link	completed
R34.htm	Edgar Link	completed
R35.htm	Edgar Link	completed
R36.htm	Edgar Link	completed
R37.htm	Edgar Link	completed
R38.htm	Edgar Link	completed
R39.htm	Edgar Link	completed
R4.htm	Edgar Link	completed
R40.htm	Edgar Link	completed
R41.htm	Edgar Link	completed
R42.htm	Edgar Link	completed
R5.htm	Edgar Link	completed
R6.htm	Edgar Link	completed
R7.htm	Edgar Link	completed
R8.htm	Edgar Link	completed
R9.htm	Edgar Link	completed
report.css	Edgar Link	completed
Show.js	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AAPL
Apple Inc. Stock $aapl

2012 Q3 Form 10-Q Financial Statement

#000119312512314552 Filed on July 25, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AAPL Apple Inc. Stock $aapl

2012 Q3 Form 10-Q Financial Statement

#000119312512314552 Filed on July 25, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AAPL
Apple Inc. Stock $aapl